Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 33,9x - 37,5x | 35,7x |
| Selected Fwd EBIT Multiple | 23,2x - 25,6x | 24,4x |
| Fair Value | ﷼43,85 - ﷼48,85 | ﷼46,35 |
| Upside | 11,5% - 24,2% | 17,8% |
| Benchmarks | Ticker | Full Ticker |
| Mouwasat Medical Services Company | 4002 | SASE:4002 |
| Al Hammadi Holding Company | 4007 | SASE:4007 |
| Dr. Sulaiman Al Habib Medical Services Group Company | 4013 | SASE:4013 |
| Middle East Healthcare Company | 4009 | SASE:4009 |
| National Medical Care Company | 4005 | SASE:4005 |
| Dr. Soliman Abdel Kader Fakeeh Hospital Company | 4017 | SASE:4017 |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| 4002 | 4007 | 4013 | 4009 | 4005 | 4017 | ||
| SASE:4002 | SASE:4007 | SASE:4013 | SASE:4009 | SASE:4005 | SASE:4017 | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | 9.0% | 16.3% | 22.1% | 33.7% | 23.6% | 3.4% | |
| 3Y CAGR | 5.2% | 31.9% | 17.1% | 101.1% | 15.7% | -1.6% | |
| Latest Twelve Months | -2.1% | -5.5% | 13.3% | 16.4% | 7.8% | -6.7% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 27.9% | 21.8% | 20.5% | 8.5% | 19.5% | 15.2% | |
| Prior Fiscal Year | 28.0% | 29.1% | 22.0% | 12.2% | 22.8% | 14.4% | |
| Latest Fiscal Year | 25.1% | 26.5% | 21.0% | 15.3% | 19.7% | 12.9% | |
| Latest Twelve Months | 25.4% | 26.1% | 20.5% | 14.5% | 20.2% | 11.8% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 5.39x | 4.84x | 7.98x | 2.55x | 5.18x | 3.51x | |
| EV / LTM EBITDA | 16.1x | 14.6x | 33.1x | 12.1x | 20.7x | 22.7x | |
| EV / LTM EBIT | 21.2x | 18.5x | 38.9x | 17.6x | 25.6x | 29.8x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | 17.6x | 21.2x | 38.9x | ||||
| Historical EV / LTM EBIT | 41.7x | 41.7x | 41.7x | ||||
| Selected EV / LTM EBIT | 33.9x | 35.7x | 37.5x | ||||
| (x) LTM EBIT | 331 | 331 | 331 | ||||
| (=) Implied Enterprise Value | 11,216 | 11,806 | 12,397 | ||||
| (-) Non-shareholder Claims * | (823) | (823) | (823) | ||||
| (=) Equity Value | 10,393 | 10,983 | 11,573 | ||||
| (/) Shares Outstanding | 230.0 | 230.0 | 230.0 | ||||
| Implied Value Range | 45.19 | 47.75 | 50.32 | ||||
| FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 45.19 | 47.75 | 50.32 | 39.34 | |||
| Upside / (Downside) | 14.9% | 21.4% | 27.9% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4002 | 4007 | 4013 | 4009 | 4005 | 4017 | |
| Enterprise Value | 15,754 | 5,706 | 94,020 | 7,405 | 7,154 | 9,871 | |
| (+) Cash & Short Term Investments | 700 | 291 | 2,548 | 282 | 677 | 400 | |
| (+) Investments & Other | 0 | 140 | 469 | 60 | 0 | 195 | |
| (-) Debt | (801) | (307) | (8,587) | (2,391) | (466) | (1,026) | |
| (-) Other Liabilities | (153) | 0 | (461) | (50) | 0 | (393) | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 15,500 | 5,830 | 87,990 | 5,306 | 7,365 | 9,048 | |
| (/) Shares Outstanding | 200.0 | 160.0 | 350.0 | 92.0 | 44.7 | 230.0 | |
| Implied Stock Price | 77.50 | 36.44 | 251.40 | 57.65 | 164.80 | 39.34 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 77.50 | 36.44 | 251.40 | 57.65 | 164.80 | 39.34 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |